Want to see IN:ANURAS full AI Analyst Report?
ANURAS Stock Chart & Stats
₹1260.10
-₹26.30(-2.10%)
At close: 4:00 PM EDT
₹1260.10
-₹26.30(-2.10%)
Day’s Range― - ―
52-Week Range₹1,047.40 - ₹1,415.40
Previous CloseN/A
Volume145.79K
Average Volume (3M)3.75K
Market Cap
₹141.01B
Enterprise Value₹131.26K
Total Cash (Recent Filing)₹4.11B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)80.5
Beta0.60
Next Earnings
Nov 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.12%
Share Statistics
EPS (TTM)15.38
Shares Outstanding113,849,840
10 Day Avg. Volume3,760
30 Day Avg. Volume3,755
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)4.16
Price to Sales (P/S)5.87
P/FCF Ratio-38.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)21.23
Revenue Forecast (FY)₹27.26B
Bulls Say, Bears Say
Bulls Say
Revenue RecoveryThe FY2026 rebound indicates demand recovery after two weaker years. Sustained growth in contract-led specialty chemicals would improve utilization and spread fixed costs, supporting earnings resilience if customer volumes continue to recover.
Healthy Operating ProfitabilityA roughly 22.2% EBITDA margin and 34.5% gross margin show meaningful value capture despite recent pressure. This profitability provides capacity to fund operations and absorb variability across end markets.
Specialty Chemicals Business ModelCustom synthesis and contract manufacturing require process expertise, scale-up capability and quality compliance. These barriers can support repeat customer relationships and longer product lifecycles, making revenue less commodity-like.
Bears Say
Weak Free Cash FlowPersistent negative free cash flow limits internally generated funding and may increase reliance on debt or external capital. If working-capital needs and reinvestment remain high, earnings growth may not translate into stronger financial flexibility.
Rising LeverageThe higher debt burden reduces balance-sheet flexibility relative to earlier years and increases sensitivity to margin weakness. Continued investment or subdued profitability could require additional funding, raising financial risk over the medium term.
Margin CompressionAlthough profitability remains solid, margins have not recovered to prior-year levels, suggesting ongoing mix pressure, cost inflation or competitive intensity. Sustained compression could constrain earnings growth and weaken the benefits of revenue recovery.
Anupam Rasayan India Ltd. News
ANURAS FAQ
What was Anupam Rasayan India Ltd.’s price range in the past 12 months?
Anupam Rasayan India Ltd. lowest stock price was ₹1047.40 and its highest was ₹1415.40 in the past 12 months.
What is Anupam Rasayan India Ltd.’s market cap?
Anupam Rasayan India Ltd.’s market cap is ₹141.01B.
When is Anupam Rasayan India Ltd.’s upcoming earnings report date?
Anupam Rasayan India Ltd.’s upcoming earnings report date is Nov 11, 2026 which is in 67 days.
How were Anupam Rasayan India Ltd.’s earnings last quarter?
Anupam Rasayan India Ltd. released its earnings results on Aug 14, 2026. The company reported ₹3.4 earnings per share for the quarter, beating the consensus estimate of ₹3.2 by ₹0.2.
Is Anupam Rasayan India Ltd. overvalued?
According to Wall Street analysts Anupam Rasayan India Ltd.’s price is currently Overvalued.
Does Anupam Rasayan India Ltd. pay dividends?
Anupam Rasayan India Ltd. pays a Annually dividend of ₹0.75 which represents an annual dividend yield of 0.12%. See more information on Anupam Rasayan India Ltd. dividends here
What is Anupam Rasayan India Ltd.’s EPS estimate?
Anupam Rasayan India Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anupam Rasayan India Ltd. have?
Anupam Rasayan India Ltd. has 113,849,840 shares outstanding.
What happened to Anupam Rasayan India Ltd.’s price movement after its last earnings report?
Anupam Rasayan India Ltd. reported an EPS of ₹3.4 in its last earnings report, beating expectations of ₹3.2. Following the earnings report the stock price went up 0.195%.
Which hedge fund is a major shareholder of Anupam Rasayan India Ltd.?
Currently, no hedge funds are holding shares in IN:ANURAS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Anupam Rasayan India Ltd.
Anupam Rasayan India Ltd., established in Surat, India, in 1984, specializes in the custom synthesis and production of specialty chemicals. The company manufactures a diverse range of life science-oriented chemicals, including intermediates and active ingredients crucial for the agrochemical sector, alongside compounds for antibacterial and ultraviolet protection applications in the personal care industry. Additionally, it provides essential intermediates and key starting materials vital for active pharmaceutical ingredients. Beyond these life science applications, Anupam Rasayan also supplies other specialized chemicals to various end-user segments, such as specialty pigments, dyes, and polymer additives. The company distributes its products both domestically and through exports.
Technical Analysis
AARTI Industries Ltd
―
Aether Industries Ltd.
―
Alkyl Amines Chemicals Limited
―
Atul Limited
―
Jubilant Ingrevia Ltd.
―